Table 3 Biomarker levels at exacerbation and 4 weeks follow-up
From: Accelerated extracellular matrix turnover during exacerbations of COPD
| Â | Exacerbation (ng/ml) | Follow-up (ng/ml) | P value |
|---|---|---|---|
C3M | 29.24 [26.32–32.49] | 22.64 [20.78–24.67] | <0.0001 |
C4M | 95.96 [85.83–107.28] | 73.30 [66.59–80.69] | <0.0001 |
C6M | 19.78 [16.82–23.27] | 13.27 [11.56–15.23] | <0.0001 |
ELM7 | 4.26 [3.90–4.64] | 3.61 [3.37–3.87] | <0.0001 |
EL-NE | 7.79 [6.30–9.63] | 5.23 [4.41–6.21] | <0.0001 |
VCANM | 1.69 [1.58–1.80] | 1.87 [1.78–1.97] | 0.0001 |
Pro-C3 | 12.10 [10.60–13.81] | 12.79 [11.35–14.42] | 0.2549 |
P4NP 7S | 510.99 [440.91–592.21] | 359.20 [312.28–413.17] | <0.0001 |
Pro-C6 | 5.36 [4.81–5.99] | 6.38 [5.71–7.14] | <0.0001 |